Neudle.com: atypical parkinsonism

Differential
(Click to cross reference)

advances in neurology

adverse drug reaction

anticholinergic drugs

anticholinergic drugs, side effects of

aphasia, progressive, primary

aphonia

applause sign

apraxia

apraxia of eyelid opening

autoimmune cerebellar ataxia

autoimmune disease

autonomic cardiovascular reflexes

autonomic dysfunction

basal ganglia, infarction

basal ganglia, lesion, bilateral

burst suppression pattern, electroencephalogram

CAT scan, emission, abnormal

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortical atrophy

cerebral infarction, subcortical

cerebrovascular accident

cerebrovascular disease

chromosome 19

cingulate island sign

Clinical Pathologic Conference(C.P.C.)

cortical-basal ganglionic degeneration

cycling

degenerative diseases of CNS

dementia, frontotemporal

dementia, subcortical

differential diagnosis

drug induced neurologic disorders

drug interactions

dyskinesia

dyskinesia, drug induced

dysphagia

dystonia

dystonia, drug induced

dystonia, face

dystonia, focal

dystonic reaction, acute

efficacy

electroconvulsive therapy

electron microscopy

emergencies, neurologic

emergency room

encephalitis, autoimmune

enzyme inhibition

epidemiology of neurology

erectile dysfunction

ergotamine

evidence-based research

extrapyramidal movement disorder, progressive

eye movement, disorders of

facial appearance, abnormal

facial expression abnormality

falling

familial

fever

fine motor function, impaired

fluoxetine

frontal behavioral spatial syndrome

gait disorder

gait, apraxic

gammaglobulin therapy, intravenous

gaze palsy

gaze palsy, supranuclear

gaze palsy, vertical

gene mutation

gene therapy

genetic neurologic disorders

genetic testing

glutamic acid decarboxylase, antibody

heralding manifestation

hypotension, neurologic causes of

hypotension, systemic

hypothyroidism

iatrogenic neurologic disorders

inclusion bodies, eosinophilic cytoplasmic

intracranial hypotension

jealousy

L-dopa

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

leg spasms, painful

leucine rich glioma inactivated 1 antibodies

leukemia, neurologic findings assoc.with

leukoencephalopathy

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

memory, impairment of

meningitis

microangiopathy, brain

midbrain

midbrain, atrophy

mimics

Mini Mental Status Examination

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

multiple sclerosis, treatment of

multiple system atrophy

neurofilament light chain protein

neurofilaments

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic disease, diagnoses of

neurologic disease, tempo

neuropathology, brain

nortriptyline

obsessive-compulsive disorder

olanzapine

old age, neurology of

ondansetron

ophthalmoplegia

ophthalmoplegia, total

orthostatic hypotension

Parkinson disease, akinetic form

Parkinson disease, arteriosclerotic

Parkinson disease, asymmetric onset

Parkinson disease, atypical

Parkinson disease, axial symptoms

Parkinson disease, benign tremulous

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinson disease, duration

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, exacerbation

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, heterogeneity of

Parkinson disease, intractable

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, nonmotor problems of

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, rapid onset

Parkinson disease, rapid progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

Parkinson disease, tremor, absence of

Parkinson disease, unilateral

Parkinson disease, wearing off

Parkinson disease, young onset

Parkinsonism hyperpyrexia syndrome

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

Parkinsonism-dementia complex

patient information and support

penguin silhouette sign

personality change

phenothiazine

phenothiazine, dyskinesia associated with

postural abnormality

practice guidelines

preclinical

primary intracranial hypotension

prognosis

progressive neurologic disorder

progressive supranuclear palsy

pseudobulbar palsy

psychiatric disorder

psychiatric problems in neurologic disorders

psychomotor retardation

psychosis

psychotic behavior

pull test

pyramidal tract dysfunction

quetiapine

rapid onset dystonia parkinsonism

rapidly progressing neurologic illness

reading disorder, acquired

reading problem, causes of

Red flags

remote effect of cancer on the nervous system

saccadic eye movements

saccadic eye movements, abnormal

safety

sagging of the brain

salivation, excessive

seizure

selective serotonin reuptake inhibitors

sequencing difficulty

serotonin syndrome

shoulder, pain in

sinemet

single photon emission computed tomography

skin, biopsy

sleep pathology and physiology

stimulation, deep brain

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamotomy

trazodone

treatment of neurologic disorder

tremor

tremor, intention

tremor, resting

tremor, surgical treatment of

tremor, treatment of

tricyclic antidepressant

urinary incontinence

vision, blurred

visual symptoms

walking, difficulty with

weight loss

wheelchair

wide based gait

Showing articles 1100 to 1150 of 1482 << Previous Next >>

Subcutaneous Apomorphine in Parkinsonian On-Off Oscillations
Lancet 1:403-406, Stibe,C.M.H.,et al, 1988

Dystonia in Parkinson's Disease:Clinical & Pharmacological Features
Ann Neurol 23:73-78, Poewe,W.H.,et al, 1988

An Estimate of the Prevalence of Dementia in Idiopathic Parkinson's Disease
Arch Neurol 45:260-262, Mayeux,R.,et al, 1988

A Double-Blind Trial of Clonazepam in the Treatment of Parkinsonian Dysarthria
Neurol 38:255-258, Biary,N.,et al, 1988

Transplantation of Fetal Substantia Nigra & Adrenal Medulla to the Caudate Nucleus in Two Patients with Parkinson's Disease
NEJM 318:51, Madrazo,I.,et al, 1988

Decreased Catecholamines in the Adrenal Medulla of Patients with Parkinsonism
NEJM 318:254, Carmichael,S.W.,et al, 1988

Protein Redistribution Diet Restores Motor Function in Patients with Dopa-Resistant"Off"Periods
Neurol 38:481-483, Pincus,J.H.&Barry,K., 1988

Prevalence and Natural History of Progressive Supranuclear Palsy
Neurol 38:1031-1034, Golbe,L.I.,et al, 1988

Cerebral Hypometabolism in Progressive Supranuclear Palsy Studied with Positron Emission Tomography
Ann Neurol 24:399-406, Foster,N.L.,et al, 1988

Neuroleptic-Induced Parkinson's Syndrome:Clinical Features and Results of Treatment with Levodopa
JNNP 51:850-854, Hardie,R.J.&Lees,A.J., 1988

Extrapyramidal Reactions to Anti-Inflammatory Drugs
JNNP 51:731-732, Wood,N.,et al, 1988

Basal Ganglia Involvement in Subacute Sclerosing Panencephalitis:CT and MR Demonstration
J Comput Assist Tomogr 12:489-491, Woodward,K.G.,et al, 1988

Coma as a Presenting Sign of Epstein-Barr Encephalitis
Arch Int Med 148:1459-1461, Demey,H.E.,et al, 1988

Extrapyramidal and Other Neurologic Manifestations Associated with Carbon Disulfide Fumigant Exposure
Arch Neurol 45:537-540, Peters,H.A.,et al, 1988

Does Levodopa Aggravate Parkinson's Disease
Neurol 38:1410-1416, Blin,J.,et al, 1988

Duodenal and Gastric Delivery of Levodopa in Parkinsonism
Ann Neurol 23:589-595, Kurlan,R.,et al, 1988

Long-Term Duodenal Infusion of Levodopa for Motor Fluctuations in Parkinsonism
Ann Neurol 24:87-89, Sage,J.I.,et al, 1988

Hemiparkinsonism with Hemiatrophy
Neurol 38:527-530, Buchman,A.S.,et al, 1988

Familial Parkinsonism, Apathy, Weight Loss & Central Hypoventilation:Successful Long-Term Management
Neurol 38:637-639, Roy,E.P.,et al, 1988

Parkinson's Disease in a Nationwide Twin Cohort
Neurol 38:1217-1219, Marttila,R.J.,et al, 1988

Comparison of the Prevalence of Parkinson's Disease in Black Populations in the Rural US & Nigeria
Neurol 38:645-646, Schoenberg,B.S.,et al, 1988

Olfactory Dysfunction in Parkinsonism:A General Deficit Unrelated to Neurologic Signs, Disease Stage, or Duration
Neurol 38:1237-1244, Doty,R.L.,et al, 1988

Lack of Association Between Essential Tremor and Parkinson's Disease
Ann Neurol 24:23-26, Cleeves,L.,et al, 1988

Transplantation of Fetal Substantia Nigra & Adrenal Medulla to the Caudate Nucleus in Two Pts with Parkinson'sDisease. Editorial
NEJM 319:370-371, , 1988

Adrenal and Nigral Transplants for Parkinson's Disease
BMJ 296:1211-1212, Pearce,J.M.S., 1988

Ethics of Fetal Brain Cell Transplants
BMJ 296:1212-1213, Gillon,R., 1988

Embryos and Parkinson's Disease
Editorial, Lancet 1:10871988., , 1988

Neural & Adrenal Medullary Transplants as a Treatment for Parkinson's & Other Neurodegenerative Disorders
NeuroView 4:May/June, Lieberman,A.,et al, 1988

Neuropsychological Effects of Brain Autograft of Adrenal Medullary Tissue for Treatment of Parkinson's Disease
Neurol 38:1442-1450, Ostrosky-Solis,F.,et al, 1988

Controlled-Release Carbidopa/Levodopa (CR4-Sinemet) in Parkinson's Disease Pts With & Without Motor Fluctuations
Neurol 38:1143-1146, Goetz,C.G.,et al, 1988

Treatment of Chronic Parkinson's Disease with Controlled-Release Carbidopa/Levodopa
Arch Neurol 45:861-864, Hutton,J.T.,et al, 1988

Practical Application of a Low-Protein Diet for Parkinson's Disease
Neurol 38:1026-1031, Riley,D.&Lang,A.E., 1988

Uneven Pattern of Dopamine Loss in the Striatum with Idiopathic Parkinson's Disease, Pathophysiologic & Clinical Implications
NEJM 318:876-880, Kish,S.J., 1988

A Study of Facial Expression in Parkinson's Disease Using a Novel Microcomputer-Based Method
JNNP 51:362-366, Katsikitis,M.&Pilowsky,I., 1988

Treatment of Dopaminomimetic Psychosis in Parkinson's Disease with Electroconvulsive Therapy
Can J Neurol Sci 15:32-34, Hurwitz,T.A.&Waterman,C., 1988

Hallervorden-Spatz Syndrome:Clinical and Magnetic Resonance Imaging Correlations
Ann Neurol 24:692-694, Sethi,K.D.,et al, 1988

Dementia and Cognitive Impairment in Parkinson's Disease
JNNP 51:1498-1502, Girotti,F.,et al, 1988

Parkinsonism Death Rates by Race, Sex, and Geography
Neurol 38:1558-1561, Kurtzke,J.F.&Goldberg,I.D., 1988

Ipsilateral Atrophy in Children with Hemispheric Cerebral Tumors:CT Findings
J Comput Assist Tomogr 12:740-743, Mutoh,K.,et al, 1988

Amitriptyline in the Treatment of Headache in Patients with Parkinson's Disease:Double-Blind Study
Neurol 38:1720-1721, Indaco,A.&Carrieri,P.B., 1988

Dystonic-Parkinsonian Syndrome after Cyanide Poisoning:Clinical and MRI Findings
JNNP 51:1345-1348, Carella,F.,et al, 1988

Risk Factors for Progressive Supranuclear Palsy
Neurol 38:1546-1552, Davis,P.H.,et al, 1988

A Creutzfeldt-Jakob Like Syndrome Due to Lithium Toxicity
JNNP 51:120-123, Smith,S.J.M.&Kocen,R.S., 1988

Creutzfeldt-Jakob Disease without Periodic Sharp Wave Complexes:A Clinical, EEG, and Path Study
Neurol 38:1056-1060, Zochodne,D.W.,et al, 1988

Observations on the Applicability of the Wartenberg Pendulum Test to Healthy, Elderly Subjects
JNNP 51:1171-1177, Brown,R.A.,et al, 1988

Pathophysiology & Clinical Assessment of Motor Symptoms in Parkinson's Disease
In Handbk of Parkinson's Disease, Marcel Dekker, Inc, New York, p997., Jankovic,J., 1987

Classification of Parkinsonism
in Handbook of Parkinson's Disease, Marcel Dekker, Inc, New York, Ch 3, p 61., Koller,W.C., 1987

Pleuropulmonary & Retroperitoneal Fibrosis Associated with Bromocriptine Treatment
JNNP 50:1706-1707, Ward,C.D.,et al, 1987

A Case-Control Study of Smoking Habits, Dementia, & Other Illnesses in Idiopathic Parkinson's Disease
Neurol 37:226-232, Rajput,A.H.,et al, 1987

Reaction Times & Attention in Parkinson's Disease
JNNP 50:1178-1183, Bloxham,C.A.,et al, 1987

Showing articles 1100 to 1150 of 1482 << Previous Next >>